Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-[(4-aminocyclohexyl)amino]-7-(propan-2-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the pyrazolo[1,5-a]pyrimidines class. It is primarily characterized as an experimental cyclin-dependent kinase 2 (CDK2) inhibitor. CDK2 is a serine/threonine protein kinase involved in cell cycle regulation and progression from G1 to S phase. Inhibition of CDK2 has been explored as a potential anticancer strategy due to its role in cell proliferation. The compound has been studied mainly in biochemical and structural biology contexts and does not have any approved therapeutic indications or known clinical development programs at this time[2][3][4].
- Other names
- 5-((4-Aminocyclohexyl)amino)-7-(propan-2-ylamino)pyrazolo(1,5-a)pyrimidine-3-carbonitrile7-{[(1r,4r)-4-Aminocyclohexyl]amino}-7-(propan-2-yloxy)pyrazolo[1,5-a]pyrimidine5-{[(trans)-4-Aminocyclohexyl]amino}-7-(isopropylamino)pyrazolo[1,5-a]pyrimidine–3-carbonitrile
02
Targets
CDK7CDK1 (Cyclin-dependent kinase 1)CDK2 (Cyclin-dependent kinase 2)CDK9 (Cyclin-dependent kinase 9)CDK5 (Cyclin-dependent kinase 5)
Beyond the preview
Go deeper on 5-[(4-aminocyclohexyl)amino]-7-(propan-2-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-[(4-aminocyclohexyl)amino]-7-(propan-2-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile.